Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Computational Biology (1)
- Advanced Manufacturing (3)
- Biology and Environment (53)
- Biology and Soft Matter (1)
- Clean Energy (46)
- Climate and Environmental Systems (2)
- Computational Engineering (2)
- Computer Science (9)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (10)
- Fusion Energy (8)
- Isotopes (2)
- Materials (34)
- Materials for Computing (5)
- Mathematics (1)
- National Security (37)
- Neutron Science (19)
- Nuclear Science and Technology (12)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (9)
- Sensors and Controls (1)
- Supercomputing (105)
News Type
Date
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.